1 / 5

Biopharma Trends to watch in 2023 _

The biopharma market is evolving competitive with the rapid adoption of novel biologics, biosimilar, and innovative technology. With around a third of the global market for biopharmaceuticals, the United States leads the way in biopharmaceutical R&D.<br><br>According to the Pharmaceutical Research and Manufacturers Association (Ph RMA), US biopharma companies achieve $75 billion nearly half of the worldu2019s pharmaceutical R&D and hold the patents on most the new drugs. <br><br>

sunilsiwach
Download Presentation

Biopharma Trends to watch in 2023 _

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 1/19/23, 11:23 AM Biopharma Trends to watch in 2023 | Biopharma Trends to watch in 2023 B2b Data (https://www.ampliz.com/resources/) » Blog (https://www.ampliz.com/resources/category/blog/) » Biopharma Trends to watch in 2023 Shares Posted by Prabhakar Alok (https://www.ampliz.com/resources/author/prabhakar-alok/) The biopharma market is evolving competitive with the rapid adoption of novel biologics, biosimilar, and innovative technology. With around a third of the global market for biopharmaceuticals, the United States leads the way in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (Ph RMA), US biopharma companies (https://www.ampliz.com/resources/top-pharmaceutical-companies/) achieve $75 billion nearly half of the world’s pharmaceutical R&D and hold the patents on most the new drugs.  To target and reach the leading biopharma companies in the US, it is signi?cant to have accurate data insights. With Ampliz biopharma email list, you can reach the target market and maximize business potential. Also, biopharma data help you know the market opportunities and identify the expert who discover the right bio drug to your treatment facilities.  https://www.ampliz.com/resources/biopharma-trends-to-watch-in-2023/ 1/5

  2. 1/19/23, 11:23 AM Biopharma companies in the US Biopharma Trends to watch in 2023 | Biopharmaceutical industries have a substantial economic impact on the United States. In the U.S., the biopharmaceutical industry employs more than 800,000 people in scienti?c research and technical support, as well as manufacturing and distribution. Target and reach the right biopharma experts to help you when you’re developing a new drug or medical device (https://www.ampliz.com/resources/top-50-medical-device-companies/). Using the biopharma data intelligence, you can bring your new bio drugs and therapies to limelight. Biopharma data provide you with accurate data insights to help you reach the key decision-makers in the biopharma market. Download the Contact Intelligence Of Biopharma Experts You’ve Been LookingForfrom the top pharma companies in the world (https://www.ampliz.com/resources/top-pharmaceutical-companies/) Shares Name * Email * Phone * Message * Tell us your requirement Submit Now In today’s day and age, it is challenging to target, reach and engage the right biopharma experts who discover the right bio drug for healthcare centers.If you’re in search of biopharma experts to combat drug procurement capital for your clinical practice, it is foremost to approach the right biopharma companies . you can gain access to the biopharma data from Ampliz (https://www.ampliz.com/) https://www.ampliz.com/resources/biopharma-trends-to-watch-in-2023/ 2/5

  3. 1/19/23, 11:23 AM Overarching trends in the biopharma industry in 2023 Biopharma Trends to watch in 2023 | The biopharma industry will continue to develop new ways to treat and cure a wide variety of diseases. Nevertheless, actionable health insights, powered by radically interoperable data and arti?cial intelligence (AI), can help clinicians and consumers know about illnesses much earlier than we do. In contemporary medicine, biopharmaceuticals have become one of the most widely used treatment alternatives for a wide range of diseases, including cancer. To meet the world’s growing need for affordable and effective life-saving medicines, biopharmaceutical companies must equip themselves with tools, strategies, and skill sets that help them optimize their manufacturing work?ows. Shares In this article, we discuss four trends that most strongly in?uence the industry’s search for a streamlined bioprocessing work?ow in 2023. Demand for the biosimilar in the emerging market Emerging nations are attracted to biosimilar products because they are cheaper than their innovative counterparts. According to McKinsey, global biosimilar sales will more than double by 2025 to $15 billion… and about $5–8 billion of these sales will come from emerging markets. As noted by the FDA, a biosimilar is “the fastest-growing class of therapeutic products in the United States.” Additionally, “biosimilar and interchangeable products can offer additional treatment options that could lower healthcare costs,” it adds. The development of biosimilar will therefore provide pharma/biotech companies with new sources of revenue and competitively priced treatments for many patients. By the summer of 2020, there were 28 biosimilars approved, and 18 had already been launched. There are 79 additional biosimilars in the approval pipeline. As the industry offers new treatment options and lower prices-expect to see more focus on this category of drugs in 2021 and beyond. Bioprocessing 4.0 Today, some of the most common bioprocessing work?ows involve advanced therapies based on genes, tissues, or cells. The US FDA has approved just ten cell and gene therapies, but there are thousands in development and the number is rising. According to the FDA, the gene therapy market is expected to grow at a 30% compound annual growth rate between 2020 and 2030. Zolgensma, manufactured by Novartis/Avexis, has shown success in treating spinal muscular atrophy. https://www.ampliz.com/resources/biopharma-trends-to-watch-in-2023/ 3/5

  4. 1/19/23, 11:23 AM Biopharma Trends to watch in 2023 | It appears that biopharmaceutical companies will expand beyond rare diseases to oncology and other chronic conditions in the future. Blockchain, bots, and the cloud in Biopharma To remain relevant in the global market, biopharma companies must remain ?exible and adapt to new technologies. Technology-driven competitors such as Amazon have entered the pharmaceutical distribution market, indicating the continued expansion of tech in the life sciences sector. New technologies, such as blockchain, bots, and the cloud, will be increasingly integrated into biotech, pharma, and MedTech ?rms. Cloud technologies will continue to transform the biopharma industry due to their ?exibility, real-time sharing, and project management capabilities. Shares Gene therapy, Genome editing, and beyond Gene therapy is poised to become a key part of the pipelines of major pharma ?rms starting in 2021 and beyond. In October, Bayer agreed to acquire Asklepios BioPharmaceutical (AskBio) for up to $4 billion.  Two days later, Novartis acquired Vedere Bio, a developer of ocular gene therapy, for up to $280 million. The company announced an agreement to invest up to $1.8 billion in Dyno Therapeutics’ CapsidMapTM platform to develop new adeno-associated virus (AAV) vectors for gene therapies for central nervous system diseases and liver diseases. Harness biopharma data to drive growth Biopharma innovation has progressed at an astonishing rate in 2020. To extend your reach and ?nd the right biopharma expert and companies. Using biopharma data, you can target the key prospects in US bio pharmacists, bio technique experts, biotechnologists, genetic engineers, drug discovery & development associates, and key decision-makers in the biopharma market.  Ampliz data intelligence can help you: Identify the perfect expert for your disease state Network and reach the associated biopharma companies and experts   Better identify, prioritize and engage the biopharma experts with precise data Tags: Biopharma (https://www.ampliz.com/resources/tag/biopharma/), Biopharma Industries (https://www.ampliz.com/resources/tag/biopharma-industries/), Biopharma Trends (https://www.ampliz.com/resources/tag/biopharma- trends/), biopharmaceutical company (https://www.ampliz.com/resources/tag/biopharmaceutical-company/), Healthcare Data (https://www.ampliz.com/resources/tag/healthcare-data/) https://www.ampliz.com/resources/biopharma-trends-to-watch-in-2023/ 4/5

  5. 1/19/23, 11:23 AM Biopharma Trends to watch in 2023 | Subscribe Our Weekly Newsletter Subscribe Enter your email Shares Book a demo (https://www.ampliz.com/book-your-demo) Cookie Policy (https://www.ampliz.com/cookie-policy) GDPR Compliance (https://www.ampliz.com/gdpr-compliance) Privacy Policy (https://www.ampliz.com/privacy-policy) Terms & Conditions (https://www.ampliz.com/terms-conditions)     USA 1900 Powell Sweet, Emeryville CA 94649, USA India L 32, 2nd A Main Road 6th Sector, Outer Ring Road, HSR Layout, Bengaluru, India Singapore Level 39, Marina Bay Financial Centre Tower 2,10 Marina Boulevard, Singapore – 018983  (https://amplizb2b-   (https://www.facebook.com/AmplizSuite/) (https://twitter.com/AmplizSuite) (https://www.linkedin.com/company/ampliz/) salesnmrktn.slack.com/) (https://www.youtube.com/channel/UCX4Uvuo4y5B4VQe7Y1j1lSA)   Copyright 2020. All rights Reserved Ampliz https://www.ampliz.com/resources/biopharma-trends-to-watch-in-2023/ 5/5

More Related